Cannavò Serafinella Patrizia, Tonacci Alessandro, Bertino Lucrezia, Casciaro Marco, Borgia Francesco, Gangemi Sebastiano
Section of Dermatology, Department of Clinical and Experimental Medicine, University of Messina, 98125, Messina, Italy.
Pisa Unit, National Research Council of Italy (CNR), Institute of Clinical Physiology (IFC), 56124 Pisa, Italy.
Pathol Res Pract. 2019 Jan;215(1):21-28. doi: 10.1016/j.prp.2018.11.020. Epub 2018 Nov 24.
Melanoma is the most aggressive skin tumour, which incidence is rising fast over the year. The metastatic stage of disease is extremely difficult to treat and the mortality rate is still high. Emerging evidence suggested that oxidative stress (OS) is involved in the pathophysiological pathways of several chronic diseases and in the transformation and progression of many common cancers, including melanoma. In particular, it has emerged that OS interacts with inflammatory and immune response, all taking part in the melanomagenic process. In light of the interest shown by the scientific community for this topic, it was analysed the association between melanoma and oxidative stress. A systematic review was performed according to PRISMA guideline employing PubMed database. It identified n = 29 articles which investigated this aspect. Melanoma cells resulted to have adaptive mechanisms to overcome effects of high reactive oxygen species (ROS) levels. Furthermore, OS influences the metastatic ability of melanoma cells and their resistance to therapy. Nonetheless, the included studies were conducted on heterogeneous patient population and with differences in the design of the studies and in the protocols. Therefore, it is mandatory performing further studies which analyze all the aspect of OS pathways: ROS imbalance, its effect to proliferation and metastasis, role of microenvironment, ROS effect to drug resistance. All this in order to understand the role of oxidative stress in the complex biology of melanoma and to provide possibilities of defining new strategy of therapy.
黑色素瘤是最具侵袭性的皮肤肿瘤,其发病率近年来迅速上升。疾病的转移阶段极难治疗,死亡率仍然很高。新出现的证据表明,氧化应激(OS)参与了几种慢性疾病的病理生理途径以及包括黑色素瘤在内的许多常见癌症的转化和进展。特别是,已经发现OS与炎症和免疫反应相互作用,所有这些都参与了黑色素瘤的发生过程。鉴于科学界对该主题的兴趣,分析了黑色素瘤与氧化应激之间的关联。根据PRISMA指南,利用PubMed数据库进行了系统综述。共识别出n = 29篇研究这方面的文章。黑色素瘤细胞具有适应性机制来克服高活性氧(ROS)水平的影响。此外,OS影响黑色素瘤细胞的转移能力及其对治疗的抗性。尽管如此,纳入的研究是在异质患者群体中进行的,研究设计和方案存在差异。因此,必须进行进一步的研究,分析OS途径的所有方面:ROS失衡、其对增殖和转移的影响、微环境的作用、ROS对耐药性的影响。所有这些都是为了了解氧化应激在黑色素瘤复杂生物学中的作用,并提供定义新治疗策略的可能性。